| Size | Price | |
|---|---|---|
| 500mg | ||
| 1g | ||
| Other Sizes |
| Targets |
O-Desmethyl mebeverine acid is formed from mebeverine by hydrolysis and subsequent oxidation and demethylation. Mebeverine acts as a musculotropic antispasmodic with direct relaxant effects on gastrointestinal smooth muscle, and the acid metabolite retains weak spasmolytic activity, although it is substantially less potent than the parent drug and serves primarily as a marker of mebeverine exposure.
|
|---|---|
| ln Vitro |
Drug compounds have included stable heavy isotopes of carbon, hydrogen, and other elements, mostly as quantitative tracers while the drugs were being developed. Because deuteration may have an effect on a drug's pharmacokinetics and metabolic properties, it is a cause for concern [1].
O-Desmethyl mebeverine acid relaxes pre-contracted isolated intestinal smooth muscle strips from guinea pigs or rats at concentrations of 1–100 μM, inhibiting carbachol-induced contractions with an IC₅₀ of approximately 5–15 μM, which is about 3–5 times less potent than mebeverine. The deuterated analogue is pharmacologically indistinguishable in terms of its low intrinsic potency and is used as an analytical reference standard. |
| ln Vivo |
In vivo, mebeverine is rapidly metabolized to O-desmethyl mebeverine acid and other metabolites. The acid metabolite circulates at measurable concentrations and is used to assess mebeverine bioavailability and metabolic clearance, with the d₆ standard enabling accurate LC-MS/MS quantification and characterization of first-pass metabolism and systemic exposure.
|
| Enzyme Assay |
O-Desmethyl mebeverine acid can be quantified in enzyme-incubation systems using liver microsomes or hepatocytes and LC-MS/MS with the d₆-labelled internal standard. Enzyme kinetic parameters (Km, Vmax) for mebeverine hydrolysis and O-demethylation are derived from substrate-depletion or metabolite-formation assays, allowing characterization of the metabolic pathways responsible for mebeverine clearance.
|
| Cell Assay |
Cellular metabolism studies use hepatocytes or intestinal cell models incubated with mebeverine, followed by LC-MS/MS quantification of O-desmethyl mebeverine acid-d₆ and other metabolites. This allows assessment of first-pass metabolism, metabolite formation rates, and potential drug–drug interactions at the metabolic level.
|
| Animal Protocol |
In vivo pharmacokinetic studies administer mebeverine orally to rodents or humans and collect plasma and urine over time. O-Desmethyl mebeverine acid is quantified by LC-MS/MS using the d₆-labelled standard to characterize mebeverine absorption, metabolism, and excretion, and to establish the relationship between parent drug exposure and metabolite formation.
|
| References |
| Molecular Formula |
C15H17D6NO3
|
|---|---|
| Molecular Weight |
271.38
|
| CAS # |
1630732-39-6
|
| Related CAS # |
O-desmethyl Mebeverine acid;586357-02-0
|
| Appearance |
Typically exists as solid at room temperature
|
| SMILES |
O=C(O)C([2H])([2H])C([2H])([2H])C([2H])([2H])N(CC)C(C)CC1=CC=C(O)C=C1
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.6849 mL | 18.4243 mL | 36.8487 mL | |
| 5 mM | 0.7370 mL | 3.6849 mL | 7.3697 mL | |
| 10 mM | 0.3685 mL | 1.8424 mL | 3.6849 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.